You are here: Industry Insights > iPSC

News List

Century Therapeutics Significantly Expands Capabilities contractpharma
February 20, 2021
Century Therapeutics, a cell therapy company developing induced pluripotent stem cell (iPSC)-derived cell therapies for cancer, announced a significant expansion of its operational and laboratory space in Philadelphia, as well as progress on its ...
RheinCell Therapeutics Achieves GMP Certification contractpharma
January 15, 2021
RheinCell Therapeutics GmbH, a developer and manufacturer of human induced pluripotent stem cells (iPSCs) as starting materials for cell therapies, has received Good Manufacturing Practice (GMP) certification and Manufacturing Authorization.
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic prnasia
December 17, 2020
Avery Therapeutics and I Peace, Inc. announced a service agreement to advance cell therapy for heart failure.
I Peace, Inc. Obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use prnasia
December 04, 2020
I Peace, Inc., a Palo Alto-based biotech start-up focusing on Nobel Prize-winning induced pluripotent stem cell (iPSC) technology obtains approval from an independent Institutional Review Board (IRB) for the process of generating iPSCs—including donor ...
Fujifilm Cellular Dynamics and Lonza Enter Cell Therapy Partnership contractpharma
November 17, 2020
Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, and Lonza Walkersville, Inc., a leading global GMP iPSC manufacturer, have entered into a partnership.
FUJIFILM Irvine Scientific Leverages Discovery Research Biz contractpharma
April 03, 2020
Aims to enable faster, efficient delivery of Cellular Dynamics iPSC-derived products for drug discovery and development.
Fujifilm Creates Discovery Research Organization contractpharma
April 02, 2020
Will provide Fujifilm Cellular Dynamics' iPSC-derived products through their worldwide distribution channels.
FUJIFILM Cellular Dynamics Opens iPSC Facility contractpharma
March 03, 2020
New Innovation Facility for Advanced Cell Therapy (i-FACT) will house development and manufacture of iPSCs for therapeutic applications.
CRISPR-based heart test pinpoints genetic risk for severe cardiomyopathy fiercebiotech
December 27, 2018
Severe hypertrophic cardiomyopathy, a dangerous disorder that causes an abnormal thickening of the heart walls, can run in families—and it’s often associated with a variant in the gene TNNT2.....
Evotec and Celgene Expand IPSC Collaboration to Include Additional Cell Lines firstwordpharma
May 30, 2018
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that the Company will receive a $ 6 m payment from Celgene following Celgene's decision to expand the collaboration to include additional cell lines.

Previous page 1 2 3 Next page